Publication:
HUMAN-LEUKOCYTE ANTIGEN SUBTYPE ANALYSIS IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE PROSTATE

Simple item page
dc.contributor.authorsAKDAS, A; TURKERI, L; ALICAN, Y; SIMSEK, F; AKOGLU, T
dc.date.accessioned2022-03-12T16:56:15Z
dc.date.accessioned2026-01-11T08:15:46Z
dc.date.available2022-03-12T16:56:15Z
dc.date.issued1994
dc.description.abstractHuman leukocyte antigens (HLA) are cell surface glycoproteins that have a significant role in the immune system. In some cancers, changes in major histocompatibility complex (MHC) class I and II expression, usually a reduction or loss of these molecules, appear to provide a mechanism whereby tumor cells may escape host immunity. HLA analysis in patients with advanced adenocarcinoma of the prostate revealed the antigens with the highest relative risk factors as DRw52, DRw53, Bw73, DR2, and B5(51). As a result, determination of HLA haplotypes may prove to be useful in determining the men with a higher risk of developing prostate cancer. (C) 1994 Wiley-Liss, Inc.
dc.identifier.doi10.1002/pros.2990240302
dc.identifier.issn0270-4137
dc.identifier.pubmed7509482
dc.identifier.urihttps://hdl.handle.net/11424/226708
dc.identifier.wosWOS:A1994NA15200001
dc.language.isoeng
dc.publisherWILEY-LISS
dc.relation.ispartofPROSTATE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGLYCOPROTEINS
dc.subjectHOST IMMUNITY
dc.subjectRELATIVE RISK FACTORS
dc.subjectCANCER RISK
dc.subjectHLA
dc.subjectEXPRESSION
dc.subjectLEUKEMIA
dc.subjectCOMPLEX
dc.titleHUMAN-LEUKOCYTE ANTIGEN SUBTYPE ANALYSIS IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE PROSTATE
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage113
oaire.citation.issue3
oaire.citation.startPage111
oaire.citation.titlePROSTATE
oaire.citation.volume24

Files

Collections

Araştırma Çıktıları